๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Immune Thrombocytopenia (ITP)

A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia NCT06776510Phase 1, Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: nicotinamide adenine dinucleotid/nicotinamide mononucleotide Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial NCT06992128Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Romiplostim N01 combined with dexamethasone, Dexamethasone monotherapy Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) NCT07234019Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Daratumumab๏ผˆAnti-CD38 Monoclonal Antibody๏ผ‰, Rituximab Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders NCT07104565Phase 239 sites๐Ÿ“ Glendale๐Ÿ“ Los Angeles๐Ÿ“ Lone Tree Incyte Corporation ยท Tests: INCA000585 A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP) NCT06094881Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Obinutuzumab Injection [Gazyva] Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia NCT06281327Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Avatrombopag Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP) NCT06838962Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Daratumumab Injection The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2) NCT07065968Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Teriflunomide, Dexamethasone CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases NCT06941129Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: UCAR T-cell CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases NCT07315087Phase 11 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: QT-019C An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases NCT07174843EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Cell Therapy Group Co.,Ltd ยท Tests: CD19/CD22/BCMA CAR-T cells(BZE2204) SG301-SC Injection Safety Study in Subjects With Primary ITP Patients NCT07710248Phase 222 sites๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou๐Ÿ“ Liuzhou Hangzhou Sumgen Biotech Co., Ltd. ยท Tests: low dose group, high dose group, Placebo group OM336 in Autoimmune Cytopenias NCT07083960Phase 17 sites๐Ÿ“ Duarte๐Ÿ“ Washington D.C.๐Ÿ“ Ann Arbor Lakefront Biotherapeutics West LLC ยท Tests: OM336 Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura NCT04323748Phase 11 site๐Ÿ“ Vahalla New York Medical College ยท Tests: rituxan Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) NCT07362199Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Rituximab combined with Daratumumab๏ผˆAnti-CD38 Monoclonal Antibody๏ผ‰ Special Drug Use-results Survey for Long-term Use (Fostamatinib) NCT06757257n/a1 site๐Ÿ“ Tokyo and Japanese Other Cities Kissei Pharmaceutical Co., Ltd. ยท Tests: fostamatinib Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura NCT07093606NA1 site๐Ÿ“ Sohag Sohag University ยท Tests: Eltrombopag Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia NCT06826430Phase 11 site๐Ÿ“ Beijing Juventas Cell Therapy Ltd. ยท Tests: Inaticabtagene autoleucel Injection A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia NCT05214391Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Zanubrutinib A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP) NCT07421167Phase 219 sites๐Ÿ“ Chandler๐Ÿ“ Fayetteville๐Ÿ“ Torrance Novartis Pharmaceuticals ยท Tests: ianalumab, thrombopoietin receptor agonist (TPO-RA) A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia NCT06544499Phase 394 sites๐Ÿ“ Phoenix๐Ÿ“ Los Angeles๐Ÿ“ Oceanside argenx ยท Tests: Efgartigimod IV, Placebo IV Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia NCT07095127Phase 23 sites๐Ÿ“ Washington D.C.๐Ÿ“ Boston๐Ÿ“ Greenville Nuvig Therapeutics, Inc. ยท Tests: NVG-2089 ITP Registry and Accompanying Biospecimen Collection NCT05152238n/a64 sites๐Ÿ“ Aachen๐Ÿ“ Altenburg๐Ÿ“ Aschaffenburg Jena University Hospital A Phase 1/2 Study of ESG206 in Patients With Primary Immune Thrombocytopenia NCT06853444Phase 1, Phase 21 site๐Ÿ“ Jinan Shanghai Escugen Biotechnology Co., Ltd ยท Tests: ESG206, ESG206, ESG206, ESG206 TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination NCT06478537Phase 21 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Hetrombopag Olamine, Aspirin A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia NCT06900920Phase 353 sites๐Ÿ“ Hefei๐Ÿ“ Wuhu๐Ÿ“ Beijing Chia Tai Tianqing Pharmaceutical Group Co., Ltd. ยท Tests: TQB3473 Tablets, TQB3473 Placebo Management of Children With Persistent ITP, A Novel Approach NCT07068126NA3 sites๐Ÿ“ Asyut๐Ÿ“ Cairo๐Ÿ“ Zagazig Assiut University ยท Tests: Mini-Pool IVIG Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia NCT07657793Phase 2, Phase 31 site๐Ÿ“ Beijing Chinese SLE Treatment And Research Group ยท Tests: Sirolimus, Placebo BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases NCT06787989Phase 11 site๐Ÿ“ Chengdu iCell Gene Therapeutics ยท Tests: BCMA-CD19 cCAR T cells An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia NCT06337474EARLY Phase 11 site๐Ÿ“ Changzhou Changzhou No.2 People's Hospital ยท Tests: anti-CD19 CAR NK cells (KN5501)
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy